Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,616.50
Bid: 1,618.00
Ask: 1,618.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,607.50
High: 1,620.00
Low: 1,594.00
Prev. Close: 1,612.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Dec 2012 07:25

AMEC: Credit Suisse reduces target price from 1300p to 1250p reiterating an outperform rating.Anglo American: Barclays upgrades to equal-weight with a target price of 1970p.Ashtead Group: Barclays raises target price from 352p to 434p and reiterates an overweight rating.ASOS: HSBC raises target price from 2590p to 2750p and keeps a neutral rating. Barclays raises target price from 3000p to 3100p maintaining an overweight rating.AstraZaneca: Deutsche Bank raises target price from 2880p to 2970p; hold rating remains unchanged.BAE Systems: Deutsche Bank moves target price from 340p to 350p reiterating a buy recommendation.Cookson Group: Citigroup downgrades to neutral with a target price of 650p.Diageo: Barclays reduces target price from 2050p to 2020p keeping its overweight rating. Nomura cuts target price from 2100p to 2070p and reiterates its buy recommendation.GlaxoSmithKline: Deutsche Bank moves target price from 1400p to 1440p and maintains a hold recommendation. Panmure Gordon raises target price from 1450p to 1500p and upgrades from hold to buy. Credit Suisse moves target price from 1430p to 1420p keeping a neutral rating.ICAP: Credit Suisse reduces target price from 350p to 320p and downgrades from outperform to neutral.IDOX: Investec raises target price from 47p to 60p and keeps its buy recommendation.IG Group: UBS cuts target price from 525p to 505p; buy rating kept.Lonmin: Credit Suisse upgrades to outperform with an target price of 525p.Meggitt: Deutsche Bank raises target price from 425p to 445p; buy recommendation unchanged.Mothercare: UBS raises target price from 230p to 250p and retains a sell recommendation.Redefine International: Peel Hunt downgrades to hold.Rolls-Royce Group: Deutsche Bank raises target price from 790p to 870p and keeps a hold recommendation.Senior: Jefferies moves target price from 233p to 236p, while keeping a buy recommendation.Shire Pharmaceuticals: Credit Suisse raises target price from 2180p to 2250p and keeps an outperform rating.Stratex International: Northland Capital reduces target price from 17.10p to 12.80p maintaining its buy recommendation.TUI Travel: Alphavalue raises target price from 260.30p to 346.40p and upgrades to buy.Tullow Oil: UBS cuts target price from 1400p to 1250p and keeps a neutral rating. Deutsche Bank reduces target price from 1180p to 1155p reiterating a hold recommendation. Barclays cuts target price from 1895p to 1845p, while maintaining an overweight rating. Credit Suisse reduces target price from 1550p to 1480p and downgrades from outperform to neutral. WH Ireland reduces target price from 1592p to 1515p, while keeping its buy recommendation. Liberum Capital moves target price from 1800p to 1760p and retains a buy rating.Ultra Electronics Holdings: Deutsche Bank downgrades to sell, while retaining target price at 1400p.Unilever: UBS raises target price from 2400p to 2590p, while maintaining its buy recommendation.Victrex: JP Morgan raises target price from 1160p to 1500p keeping a neutral rating. HB Markets upgrades to buy.Whitbread: JP Morgan raises target price from 2500p to 2650p; overweight rating remains unchanged.WPP Group: JP Morgan raises target price from 1004p to 1054p and retains an overweight rating.
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.